Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;22(8):513–518. doi: 10.1002/clc.4960220805

Heart rate and catecholamine contribution to qt interval shortening on exercise

Patrick Davey 1,, Jeffrey Bateman 1
PMCID: PMC6656000  PMID: 10492840

Abstract

Background: QT interval shortens with exercise. Some of this shortening is due to an increase in heart rate, and some is due to other effects of exercise, probably mostly neuroendocrine effects. Data from subjects with cardiac transplants have suggested that non‐heart rate‐related changes in QT interval on exercise are due to the effects of circulating catecholamines.

Hypothesis: We sought to determine whether changes in plasma catecholamine levels with exercise are an important contributor to non‐heart rate‐related QT interval shortening.

Methods: Subjects with DDD pacemakers were recruited. Subjects had QT intervals measured at rest, during a low fixed level exercise test designed to increase heart rate to about 110 beats/min, and, after resting, during pacing at a heart rate of 110 beats/min. Catecholamine levels were measured at each stage of the study.

Results: QT interval at rest was 420 ± 12 ms, during pacing 366 ± 16 ms, and on exercise 325 ± 14 ms. This then gave the proportion of QT interval shortening due to heart rate as 68.6 ± 9.3% of total QT shortening, with the range between 35 and 95.6%. There was no proportionality between the degree of QT interval shortening on exercise that was not due to increases in heart rate and changes in plasma catecholamine levels.

Conclusion: Two‐thirds of exercise‐induced QT interval shortening are due to an increase in heart rate, and one‐third to other effects. Changes in plasma catecholamine levels on exercise were not closely related to changes in the QT interval on exercise.

Keywords: QT interval, exercise, catecholamines, pacemaker

Full Text

The Full Text of this article is available as a PDF (582.9 KB).

References

  • 1. Arnold L, Page J, Attwell D, Cannell M, Eisner DA: The dependence on heart rate of the human ventricular action potential duration. Cardiovasc Res 1982; 16: 547–551 [DOI] [PubMed] [Google Scholar]
  • 2. Browne KF, Zipes DP, Heger JJ, Prystowsky EN: Influence of the autonomic nervous system on the QT interval in man. Am J Cardiol 1982; 50: 1099–1103 [DOI] [PubMed] [Google Scholar]
  • 3. Rickards AF, Norman J: Relation between QT interval and heart rate. Br Heart J 1981; 45: 56–61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Fananapazir L, Bennett DH, Faragher EB: Contribution of heart rate to QT interval shortening during exercise. Eur Heart J 1983; 4: 265–271 [DOI] [PubMed] [Google Scholar]
  • 5. Lau CP, Freedman AR, Fleming S, Malik M, Camm AJ, Ward DE: Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate. Cardiovasc Res 1988; 22: 67–72 [DOI] [PubMed] [Google Scholar]
  • 6. Fei L, Slade AK, Grace AA, Malik M, Camm AJ, McKenna WJ: Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: Risk stratification and effect of low dose amiodarone. Pacing Clin Electrophysiol 1994; 17: 2222–2227 [DOI] [PubMed] [Google Scholar]
  • 7. Abildskov JA: Neural mechanisms involved in the regulation of ventricular repolarization. Eur Heart J 1985; 6 (suppl D): 31–39 [DOI] [PubMed] [Google Scholar]
  • 8. Arrowood JA, Kline J, Simpson PM, Quigg RJ, Pippin JJ, Nixon JV, Mohanty PK: Modulation of the QT interval: Effects of graded exercise and reflex cardiovascular stimulation. J Appl Physiol 1993; 75: 2217–2223 [DOI] [PubMed] [Google Scholar]
  • 9. McCance AJ, Forfar JC: Selective enhancement of the cardiac sympathetic response to exercise by anginal chest pain in humans. Circulation 1989; 80: 1642–1651 [DOI] [PubMed] [Google Scholar]
  • 10. McCance AJ, Forfar JC: Noradrenaline kinetics and coronary haemodynamics during acute beta 1‐adrenoceptor blockade in man. Clin Sci (Colch) 1993; 84: 413–417 [DOI] [PubMed] [Google Scholar]
  • 11. Algra A, Roelandt JRTC, Tijssen JGP, Simoons ML, Pool J: Effect of ß‐blockers on the relation between QT‐interval and heart rate in exercise ECG. Eur Heart J 1987; 8 (D): 71–74 [DOI] [PubMed] [Google Scholar]
  • 12. Milne JR, Ward DE, Spurell RA, Camm AJ: The ventricular paced QT interval—the effects of rate and exercise. Pacing Clin Electrophysiol 1982; 5 (3): 352–358 [DOI] [PubMed] [Google Scholar]
  • 13. Pehrsson SK, Hjemdahl P, Nordlander R, Astrom H: A comparison of sympatho‐adrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronised pacing. Br Heart J 1988; 60 (3): 212–220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Taylor JA, Morillo CA, Eckberg DL, Ellenbogen KA: Higher sympathetic activity during ventricular (VVI) than during dual‐chamber (DDD) pacing. J Am Coll Cardiol 1996; 28 (7): 1753–1758 [DOI] [PubMed] [Google Scholar]
  • 15. Jordaens L, Backers J, Moermans E, Clement DL: Catecholamine levels and pacing behaviour of QT‐driven pacemakers during exercise. Pacing Clin Electrophysiol 1990; 13 (5): 603–607 [DOI] [PubMed] [Google Scholar]
  • 16. Bexton RS, Vallin HO, Camm AJ: Diurnal variation of the QT interval—influence of the autonomic nervous system. Br Heart J 1986; 55: 253–258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Lo SS, Sutton MS, Leslie RD: Information on type 1 diabetes mellitus and QT interval from identical twins. Am J Cardiol 1993; 72: 305–309 [DOI] [PubMed] [Google Scholar]
  • 18. Hanson B, Tuna N, Bouchard T, Heston L, Eckert E, Lykken D, Segal N, Rich S: Genetic factors in the electrocardiogram and heart rate of twins reared apart and together. Am J Cardiol 1989; 63: 606–609 [DOI] [PubMed] [Google Scholar]
  • 19. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A: Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690–695 [PubMed] [Google Scholar]
  • 20. Reardon M, Malik M: QT interval change with age in an overtly healthy older population. Clin Cardiol 1996; 19: 949–952 [DOI] [PubMed] [Google Scholar]
  • 21. Ashman R: The normal duration of the QT interval. Am Heart J 1942; 23: 522–534 [Google Scholar]
  • 22. Simonson E, Cady LD, Woodbury M: The normal QT interval. Am Heart J 1962; 63: 747–753 [DOI] [PubMed] [Google Scholar]
  • 23. Murakawa Y, Inoue H, Nozaki A, Sugimoto T: Role of sympathovagal interaction in diurnal variation of QT interval. Am J Cardiol 1992; 69: 339–343 [DOI] [PubMed] [Google Scholar]
  • 24. Browne KF, Prystowsky E, Heger JJ, Chilson DA, Zipes DP: Prolongation of the QT interval in man during sleep. Am J Cardiol 1983; 52: 55–59 [DOI] [PubMed] [Google Scholar]
  • 25. Schwartz PJ, Zaza A, Locati E, Moss AJ: Stress and sudden death. The case of the long QT syndrome. Circulation 1991; 83: 1171–1180 [PubMed] [Google Scholar]
  • 26. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr.: The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991; 84: 1136–1144 [DOI] [PubMed] [Google Scholar]
  • 27. Cooke RA, Chambers JB, Singh R, Todd GJ, Smeeton NC, Treasure J, Treasure T: QT interval in anorexia nervosa. Br Heart J 1994; 72: 69–73 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Zuckerman E, Yeshurun D, Goldhammer E, Shiran A: 24 h electrocardiographic monitoring in morbidly obese patients during short‐term zero calorie diet. Int J Obes Relat Metab Disord 1993; 17: 359–361 [PubMed] [Google Scholar]
  • 29. Thwaites BC, Bose M: Very low calorie diets and pre‐fasting prolonged QT interval. A hidden potential danger. West Indian Med J 1992; 41: 169–171 [PubMed] [Google Scholar]
  • 30. Pringle TH, Scobie IN, Murray RG, Kesson CM, Maccuish AC: Prolongation of the QT interval during therapeutic starvation: A substrate for malignant arrhythmias. Int J Obes 1983; 7: 253–261 [PubMed] [Google Scholar]
  • 31. Day CP, James OF, Butler TJ, Campbell RW: QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993; 341: 1423–1428 [DOI] [PubMed] [Google Scholar]
  • 32. Bender KS, Shematek JP, Leventhal BG, Kan JS: QT interval prolongation associated with anthracycline cardiotoxicity. J Pediatr 1984; 105: 442–444 [DOI] [PubMed] [Google Scholar]
  • 33. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J: QTc prolongation measured by standard 12‐lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991; 83: 1888–1894 [DOI] [PubMed] [Google Scholar]
  • 34. Schwartz PJ, Wolf S: QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57 (6): 1074–1077 [DOI] [PubMed] [Google Scholar]
  • 35. Ahnve S: QT interval prolongation in acute myocardial infarction. Eur Heart J 1985; 6 (suppl D): 85–95 [DOI] [PubMed] [Google Scholar]
  • 36. Pohjola‐Sintonen S, Siltanen P, Haapakoski J: Usefulness of QTc interval on the discharge electrocardiogram for predicting survival after acute myocardial infarction. Am J Cardiol 1986; 57: 1066–1068 [DOI] [PubMed] [Google Scholar]
  • 37. Peters RW, Byington RP, Barker A, Yusef S: Prognostic value of prolonged ventricular repolarisation following myocardial infarction: The BHAT experience. J Clin Epidemiol 1990; 43 (2): 167–172 [DOI] [PubMed] [Google Scholar]
  • 38. Wolf S: Oscillatory functions affecting outcome of coronary heart disease: The hazard of too much or too little stability. Integr Physiol Behav Sci 1995; 30: 118–126 [DOI] [PubMed] [Google Scholar]
  • 39. Anderson KP, Walker R, Dustman T, Lux RL, Ershler PR, Kate RE, Urie PM: Rate‐related electrophysiologic effects of long‐term administration of amiodarone on canine ventricular myocardium in vivo. Circulation 1989; 79: 948–958 [DOI] [PubMed] [Google Scholar]
  • 40. Pollak PT, Sharma AD, Carruthers SG: Correlation of amiodarone dosage, heart rate, QT interval and corneal microdeposits with serum amiodarone and desethylamiodarone concentrations. Am J Cardiol 1989; 64: 1138–1143 [DOI] [PubMed] [Google Scholar]
  • 41. Baerman JM, Annesley T, Di Carlo LA Jr, Foley MK, Nicklas JM, Crevey BJ, Morady F: Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long‐term amiodarone treatment. Am Heart J 1986; 111: 644–648 [DOI] [PubMed] [Google Scholar]
  • 42. Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, Miura DS, Somberg JC: QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol 1986; 7: 142–147 [DOI] [PubMed] [Google Scholar]
  • 43. Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN: Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Am J Cardiol 1988; 61: 1024–1030 [DOI] [PubMed] [Google Scholar]
  • 44. Ahnve S, Lundman T: QTc intervals at discharge after acute myocardial infarction and long‐term prognosis. Acta Med Scand 1980; 208: 55–60 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES